fw: Electromagnetic Devices Offer Alternative Treatments for Life-Threatening Illnesses

[Guest guest]

from:

http://www.mercola.com/2003/feb/22/electromagnetic_treatment.htm

 

Electromagnetic Devices Offer Alternative Treatments for

Life-Threatening Illnesses

 

By Paul J. Rosch, M.D., F.A.C.P.

President, The American Institute of Stress

Clinical Professor of Medicine and Psychiatry, New York Medical College

 

Clinical Professor of Medicine and Psychiatry, New York

Medical College

 

Obtaining FDA Approval for Innovative Therapies

 

Medical device manufacturers have long complained about the

difficulty in obtaining FDA approval for their products

because of very delayed or no response to inquiries.

 

This is a particular problem for cancer patients who must

travel abroad to receive therapies that are not available

here in the United States. In response to mounting

criticisms, the FDA Modernization Act of 1997 was passed to

address these and other concerns. It mandated that

correspondence would be answered in timely fashion as well

as other revisions to ensure the timely availability of safe

and effective new products.

 

One of these was a " globalization and harmonization "

provision stipulating that devices approved by regulatory

agencies abroad requiring strict proof of safety and

efficacy should be made available here, provided that post

marketing surveillance was instituted to guarantee safety.

 

The FDA was also directed to establish policies for the

" compassionate use " of these and other investigational

approaches through a licensed physician while they underwent

regulatory view. Although these provisions went into effect

in 2002, they have not been implemented.

 

I am one of five individuals selected to testify before a

Congressional Oversight Committee investigating this and

have five or ten minutes to explain my qualifications and

provide examples of devices and approaches proven worthwhile

elsewhere in the world that should be approved here in the

United States.

 

By coincidence, I have just finished editing a 52-chapter

book, “Bioelectromagnetic Medicine,” to be published later

this year by Marcel Dekker. Although it includes several

devices that should be mentioned, I intend to focus on two

cancer therapies I am personally familiar with for the

following reasons.

 

The FDA's responsibility is to protect the public by

monitoring such things as the safety of foods and

pharmaceuticals as well as medical devices. However, it must

establish priorities because of limited resources,

especially with respect to personnel with expertise in the

evaluation of electromagnetic field therapies. There are

some that are authentic and have been thoroughly

investigated by reputable researchers.

 

Unfortunately, these are drowned out by others being

promoted by well-meaning but misguided zealots as well as

entrepreneurs and charlatans who make extravagant and

unsupported claims for their worthless wares. Alleged

remarkable results are usually based on lavish testimonials,

occasionally by paid celebrities, and it is likely that any

legitimate benefits are placebo effects.

 

This is especially true because double blind studies

designed to exclude this for drugs may be impossible to

perform with some devices. As a result, it can be difficult

to separate the wheat from the chaff.

 

In addition, there is a growing wariness of the possible

harmful effects of electromagnetic fields emanating from

high power lines and cell phones. The FDA should not be

criticized for exercising extreme caution in approving

devices whose adverse effects decades later are unknown. I

have tried to address this in “Bioelectromagnetic Medicine”

by limiting contributions to those that are evidence-based

and supported by citations in peer-reviewed publications.

 

While there is no guarantee that this resolves the long-term

safety issue, this is of much less concern to cancer

patients in contrast to children or adolescents.

 

Electromagnetic Devices for Treating Cancer

 

Björn Nordenström, M.D., Ph.D. has impeccable credentials.

He was formerly chairman of the Department of Radiology at

Karolinska Hospital and chairman of the selection committee

that picks the Nobel Laureate for Physiology of Medicine. He

is famous for having developed the " skinny needle " technique

for biopsies used by most surgeons and interventional

radiologists around the world.

 

About four decades ago, he became intrigued by the

observation that he could occasionally see what appeared to

be a halo around malignancies on routine chest X-rays that

was not present with benign tumors. He collected a series of

these and showed them to colleagues who had also noted this

but assumed they were artifacts.

 

His subsequent detailed animal experiments revealed that the

reason was malignant tumors had different electrical

characteristics from surrounding normal tissue. He found

that correcting this by inserting his skinny needles into

these two areas and using them as electrodes to supply weak

DC current caused these malignancies to disappear.

 

The procedure is painless and takes only a few hours. At our

1998 Congress, he showed two patients with inoperable

pulmonary metastases from cancer of the ovary and breast

that were well with no evidence of tumor 10 and 12 years

later. As noted in “Bioelectromagnetic Medicine,” one is now

in her 90s and in good health more than 20 years after one

treatment.

 

Others have now replicated these results and a chapter from

Chinese Physicians reports on satisfactory results in over

9,000 patients with these and other malignancies. Another

chapter deals with Nordenström's description of an

" electrical circulatory system " and its relationship to

ancient Oriental concepts of Qi, yin and yang.

 

In award-winning writer Gary Taubes' Discover magazine cover

story, he noted that some authorities compared this as being

as important as William Harvey's explanation of how blood

circulates in the body and described it as " the most

profound biomedical discovery of the century. "

 

Demetrio Sodi Pallares is a respected Mexican cardiologist

and the author of 20 texts including a dozen on the

electrocardiogram. He became internationally famous decades

ago for his glucose-insulin-potassium " polarizing solution "

that dramatically improved survival following a heart

attack.

 

It was based on his observation that this increased the

production of ATP, the source of energy for all cellular

functions. He subsequently found that the application of a

pulsed magnetic field enhanced this effect in injured cells

and that combining these treatments provided amazing

benefits in other disorders. He has shown at our Congresses

how he has been able to actually reverse advanced metastatic

disease and terminal cardiomyopathy.

 

Patients whose life expectancy was a few weeks or months

were leading normal lives with no evidence of their disease

two or three years later. In “Bioelectromagnetic Medicine”

he included patients with pancreatic cancer, which is almost

always fatal within a year of detection, who are well three

years later and the reasons why his treatment works are

explained.

 

Why should cancer patients have to travel abroad for these

proven life saving therapies?

 

Electromagnetic Medicine and Osteoarthritis

 

Many suspect that powerful pharmaceutical interests have

been able to exert their influence over the FDA and other

regulatory agencies to prevent anything that threatens their

huge profits. Another chapter in “Bioelectromagnetic

Medicine” describes an electromagnetic device for the

treatment of osteoarthritis currently administered in 18

countries at over 500 sites including University affiliated

clinics and The American Hospital in Paris.

 

This non-invasive and painless therapy, consisting of

treatment for one hour daily over 10 days is reimbursed by

fiscal intermediaries and often governmental agencies that

are the equivalent of Medicare because of its proven

long-term cost effectiveness and superior safety record

compared to drugs.

 

This is important since the latest statistics indicate that

osteoarthritis now affects one in three U.S. adults (70

million), up 63 percent from the 1997 estimate of one in

five. Current medications are not always effective and can

be dangerous.

 

In 1993, of 140,000 hospital admissions for osteoarthritis,

25,000 deaths were directly attributed to high dosage or

prolonged use of NSAIDs.

 

While Cox-2 inhibitors were touted to be safer, this has now

been questioned and one has been linked to a higher

incidence of coronary events and they are no more effective

than drugs a fraction of their cost. Since their

introduction in 1999, combined sales of Vioxx and Celebrex

have exceeded $6 billion annually due to aggressive

advertising, which also drives up their price.

 

In 2000, Merck spent $161 million on advertising for Vioxx,

more than Pepsico spent on Pepsi and Anheuser-Busch spent on

Budweiser. And if you don't think that advertising and

samples bring in big bucks, consider this. One study found

that in treating patients with hypertension, over 90 percent

of physicians actually dispensed a sample that differed from

their preferred drug choice! It's not likely that these drug

giants and others will tolerate anything that threatens

their huge profits.

 

Dr. Paul J. Rosch is the president of the American Institute

of Stress and clinical professor of medicine at New York

Medical College and has written extensively about

relationships between stress and cancer over the past 25

years. He is also a member of the contributing editors board

at Mercola.com. In addition to the research noted above,

additional chapters in " Bioelectromagnetic Medicine " are

devoted to cancer as well as depression, anxiety, insomnia,

tinnitus, migraine, multiple sclerosis, obesity, epilepsy,

herniated disc, Parkinson's disease, urinary incontinence,

macular degeneration, cardiac and brain lesions. These

cutting edge " energy medicine " approaches are much safer

than drugs and surgical procedures, considerably less costly

and, in many instances, more effective. " Bioelectromagnetic

Medicine " will be published by Marcel Dekker, Inc. later

this year.

[Guest guest]

Hehe...I just posted the same article over here John after getting Cliff's

comments on the Flax list. It is a very good article and I appreciate you

sharing it.

 

Ken

-

John Draper

Gettingwell

Saturday, February 22, 2003 10:06 AM

fw: Electromagnetic Devices Offer Alternative

Treatments for Life-Threatening Illnesses

 

 

from:

http://www.mercola.com/2003/feb/22/electromagnetic_treatment.htm

 

Electromagnetic Devices Offer Alternative Treatments for

Life-Threatening Illnesses

 

By Paul J. Rosch, M.D., F.A.C.P.

President, The American Institute of Stress

Clinical Professor of Medicine and Psychiatry, New York Medical College

 

Clinical Professor of Medicine and Psychiatry, New York